Immunohistochemical Evaluation of Perlecan (Heparan Sulphate Proteoglycan 2) Expression in Invasive Female Breast Carcinoma.
Samar Ibrahim Amer IsmailEngy Talaat HelmyAhmed Mahmoud Abdel AzizPassant Essam Eldin ShibelPublished in: Asian Pacific journal of cancer prevention : APJCP (2023)
Perlecan expression measured by immunohistochemical staining is associated with aggressive characteristics in breast cancer, suggesting that Perlecan may help in cancer progression and can be investigated as a possible target therapy.